---
document_datetime: 2023-09-21 21:18:03
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/lynparza-epar-all-authorised-presentations_en.pdf
document_name: lynparza-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9484445
conversion_datetime: 2025-12-17 14:53:43.194248
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Pack size                        |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|----------------------------------|
| EU/1/14/959/002  | Lynparza          | 100 mg     | Film-coated tablet    | Oral use                  | blister (alu/alu)     | 56 tablets                       |
| EU/1/14/959/003  | Lynparza          | 100 mg     | Film-coated tablet    | Oral use                  | blister (alu/alu)     | 112 (2 x 56) tablets (multipack) |
| EU/1/14/959/004  | Lynparza          | 150 mg     | Film-coated tablet    | Oral use                  | blister (alu/alu)     | 56 tablets                       |
| EU/1/14/959/005  | Lynparza          | 150 mg     | Film-coated tablet    | Oral use                  | blister (alu/alu)     | 112 (2 x 56) tablets (multipack) |